Items where authors include "Langdahl, B."

Article

Hald, J.D., Weir, C., Keerie, C. et al. (40 more authors) (2025) Baseline characteristics of the TOPaZ study: randomised trial of teriparatide and zoledronic acid compared with standard care in adults with osteogenesis imperfecta. Calcified Tissue International, 116 (1). 136. ISSN 0171-967X

Langdahl, B., Chung, Y.-S., Plebanski, R. et al. (13 more authors) (2025) Proposed denosumab biosimilar SB16 vs reference denosumab in postmenopausal osteoporosis: phase 3 results up to month 12. The Journal of Clinical Endocrinology & Metabolism, 110 (6). dgae611. ISSN 0021-972X

Chung, Y.-S., Langdahl, B., Plebanski, R. et al. (14 more authors) (2025) SB16 versus reference denosumab in postmenopausal women with osteoporosis: 18-month outcomes of a phase III randomized clinical trial. Bone, 192. 117371. ISSN 8756-3282

Pepe, J., Body, J.-J., Hadji, P. et al. (8 more authors) (2020) Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. The Journal of Clinical Endocrinology & Metabolism, 105 (8). pp. 2487-2506. ISSN 0021-972X

van de Laarschot, D.M., McKenna, M.J., Abrahamsen, B. et al. (6 more authors) (2020) Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. The Journal of Clinical Endocrinology & Metabolism, 105 (5). pp. 1682-1699. ISSN 0021-972X

Hadji, P., Aapro, M.S., Body, J-J. et al. (18 more authors) (2017) Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. Journal of Bone Oncology, 7. pp. 1-12. ISSN 2212-1374